Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) FCF Margin (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed FCF Margin for 6 consecutive years, with 13.85% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2938.0% to 13.85% in Q4 2025 year-over-year; TTM through Dec 2025 was 16.22%, a 2813.0% increase, with the full-year FY2025 number at 16.22%, up 2813.0% from a year prior.
  • FCF Margin was 13.85% for Q4 2025 at PROCEPT BioRobotics, down from 3.25% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 3.25% in Q3 2025 to a low of 214.1% in Q1 2021.
  • A 5-year average of 89.45% and a median of 86.07% in 2023 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -92232bps in 2021, then skyrocketed 9535bps in 2024.
  • PROCEPT BioRobotics' FCF Margin stood at 162.63% in 2021, then surged by 30bps to 113.26% in 2022, then increased by 15bps to 96.74% in 2023, then skyrocketed by 55bps to 43.24% in 2024, then surged by 68bps to 13.85% in 2025.
  • Per Business Quant, the three most recent readings for PRCT's FCF Margin are 13.85% (Q4 2025), 3.25% (Q3 2025), and 23.1% (Q2 2025).